Figure 1 (Figure 1)
Imfinzi Injection, Solution
Product Images NDC 0310-4500
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Imfinzi (NDC 0310-4500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
0310_4611_50 (Image1)
This appears to be a drug information label containing important details about how to administer an injection medication via intravenous infusion. The label advises proper storage from 2 to 8 degrees Celsius and cautions against freezing or shaking. It also emphasizes the importance of protecting the drug from light and not using it if the vial seal is broken or missing. The label instructs the pharmacist to dispense a medication guide to each patient and provides a product code and information about the manufacturer, Astrazeneca.*
Fig2 (Figure2 01)
This table appears to show the probability of OS (overall survival) over time from randomisation (in months) for a group of patients. The patients were possibly divided into two treatment groups: one group received DNFINZI and chemotberspy, while the other group received treatment identified as "e w2". The number of patients at risk (i.e. still alive) decreases over time. The last column of the table is not legible with the given text.*
0310_4500_12 (Image 01)
The text is a mixture of a drug name, dosage information, and instructions for medical personnel. The drug is called "durvalumab" and is administered through an intravenous infusion after dilution. The recommended storage temperature is 2-8°C, and any unused portion should be discarded. There is a note to pharmacists to dispense the medication with an accompanying medication guide for the patient. The text seems to be missing some crucial information and is not sufficient for a comprehensive description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
